[go: up one dir, main page]

MY157594A - Compositions of matter useful in the treatment of viral infections derived from plant extracts - Google Patents

Compositions of matter useful in the treatment of viral infections derived from plant extracts

Info

Publication number
MY157594A
MY157594A MYPI97004326A MYPI9704326A MY157594A MY 157594 A MY157594 A MY 157594A MY PI97004326 A MYPI97004326 A MY PI97004326A MY PI9704326 A MYPI9704326 A MY PI9704326A MY 157594 A MY157594 A MY 157594A
Authority
MY
Malaysia
Prior art keywords
compositions
virus
hepatitis
hiv
treatment
Prior art date
Application number
MYPI97004326A
Inventor
Hsiu-Hsien Tsai
Shie-Ming Hwang
Original Assignee
Sage R & D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sage R & D filed Critical Sage R & D
Priority to MYPI97004326A priority Critical patent/MY157594A/en
Publication of MY157594A publication Critical patent/MY157594A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

THIS INVENTION RELATES TO COMPOSITIONS DERIVED FROM CHINESE HERBAL MEDICINES, MEDICINAL PLANTS AND EXTRACTS THEREOF, AND TO THEIR USE FOR THE TREATMENT OF ANIMALS INFECTED WITH VIRUSES, ESPECIALLY WITH HEPATITIS B VIRUS (HBV), HEPATITIS C VIRUS (HCV), AND HUMAN IMMUNODEFICIENCY VIRUS (HIV). MORE SPECIFICALLY, THE COMPOSITIONS OF THE PRESENT INVENTION ARE DERIVED FROM VARIOUS CHINESE HERBAL MEDICINES OR MEDICINAL PLANTS WHICH HAVE A LONG HISTORY OF HUMAN CONSUMPTION. THE COMPOSITIONS OF THE INVENTION ARE OBTAINED THROUGH SPECIFIC TECHNIQUES AND HAVE DEMONSTRATED OUTSTANDING EFFICACY FOR TREATING HUMAN HBV CARRIERS AND HEPATITIS C PATIENTS. COMPOSITIONS ACCORDING TO THE INVENTION HAVE ALSO EXHIBITED IN VITRO ANTIVIRAL ACTIVITIES AGAINST MURINE LEUKEMIA VIRUS (MULV) AND HIV. HIV IS THE VIRUS KNOWN TO CAUSE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) IN HUMANS AND AIDS PRESENTS SPECIAL PROBLEMS TO THE MEDICAL COMMUNITY WHICH THE PRESENT INVENTION ADDRESSES.
MYPI97004326A 1997-09-17 1997-09-17 Compositions of matter useful in the treatment of viral infections derived from plant extracts MY157594A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI97004326A MY157594A (en) 1997-09-17 1997-09-17 Compositions of matter useful in the treatment of viral infections derived from plant extracts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI97004326A MY157594A (en) 1997-09-17 1997-09-17 Compositions of matter useful in the treatment of viral infections derived from plant extracts

Publications (1)

Publication Number Publication Date
MY157594A true MY157594A (en) 2016-06-20

Family

ID=56567752

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI97004326A MY157594A (en) 1997-09-17 1997-09-17 Compositions of matter useful in the treatment of viral infections derived from plant extracts

Country Status (1)

Country Link
MY (1) MY157594A (en)

Similar Documents

Publication Publication Date Title
WO1998001144A2 (en) Antiviral agents from plant extracts and use for treatment of viral infections
CA2271622A1 (en) Antiviral agents from plant extracts and use for treatment of viral infections
WO2003051306A3 (en) N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
ATE264914T1 (en) ANTIVIRAL PROTEINS, DNA CODING THEREOF, AND USE THEREOF
WO2001010456A3 (en) Peptides that block viral infectivity and methods of use thereof
DE60229677D1 (en) Long acting fusion peptide inhibitors against HIV infection
ES2187530T3 (en) PEPTIDES TO REDUCE T CTITOTOXY LYMPHOCYTE RESPONSES TO HEPATITIS B VIRUSES.
GEP20084377B (en) Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections
BR9913333A (en) Inhibition and treatment of hepatitis b virus and flaviviruses with helioxatin and its analogs
WO2007033444A3 (en) Antiviral therapy with carbohydrate binding agents
EP0681578A1 (en) AGAINST VIRUSES EFFECTIVE NAPHTOCHINONE COMPOUNDS, COMPOSITIONS AND THEIR USE.
MY157594A (en) Compositions of matter useful in the treatment of viral infections derived from plant extracts
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
DK720588A (en) RELATIONSHIPS TO USE IN TREATMENT OR PREVENTION OF HUMAN IMMUNE INFECTIVE VIRUS (HIV) INFECTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
CA2401295A1 (en) Process for preparing an anti viral medicinal product from plant extracts
RU93058325A (en) APPLICATION OF 1,3-OXATHIOLANE DERIVATIVES FOR PRODUCTION OF MEDICINES FOR THE TREATMENT OR PREVENTION OF HEPATITIS B VIRAL INFECTION, APPLICATION OF 1,3 - OXATHYOLANE DERIVATIVES FOR THE TREATMENT OF HEPATITIS
BG101175A (en) TRIUM ANTI-LIV COMBINATION
UA41338C2 (en) METHOD OF INHIBITION OF RETROVIRUS INFECTION CAUSED BY HUMAN IMMUNODEFICIENCY VIRUS (HIV), METHOD OF IMMUNIDUF IMMUNODE VIRUS INHIBITION
DE69922642D1 (en) VIRAL CHIMERS FROM CAEV AND HIV-1 GENETIC ELEMENTS
BR0008269A (en) Use of drug of m. vaccae, and, method for the treatment of chronic viral infection, excluding HIV infection
WO2001030325A3 (en) Use of a bis-peroxovanadium compound for the treatment of immunosuppressed patients
BR0207931A (en) Natural Antibodies Active Against HIV Viruses
FI943295A0 (en) Piliostigma thonningii extracts, their use and Piliostigma thonningii extracts, their use and formulations containing them Formulations containing them
WO2002009677A3 (en) Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs
TH36194A (en) Antiviral agents obtained from plant extracts and their use for the treatment of viral infections.